Two Countdowns, One Card: The Medicare Advantage Trap

A Medicare Advantage member who hit his plan's out-of-pocket maximum kept receiving pharmacy bills because Medicare Advantage plans track medical and prescription drug spending on two entirely separate out-of-pocket counters, even though both sit behind a single insurance card.

A Medicare Advantage member did what every enrollee is told to think of as the end of the road: he spent his way to his plan's out-of-pocket maximum. Then the pharmacy charged him again. And again. The bills were not errors, and the plan was not overcharging him. He had simply run into an accounting rule that almost no member is told about in plain language — the plan was keeping two separate tallies of his money, and he had only finished one of them.

The case, reported by 24/7 Wall St, is a small story with a wide footprint. Roughly half of the Medicare-eligible population now sits in a Medicare Advantage plan, and the single-card, single-plan design is precisely what these products sell themselves on. That design is exactly what makes the two-counter rule so easy to miss.

What an out-of-pocket maximum actually covers

An out-of-pocket maximum — insurers and regulators call it the MOOP — is the ceiling on what a member pays in cost sharing during a plan year before the plan picks up the rest. In a Medicare Advantage plan, that ceiling applies to the medical side of the benefit: the services that Original Medicare would classify as Part A and Part B. Hospital stays. Doctor visits. Outpatient procedures. Imaging. Skilled nursing. Durable medical equipment. Deductibles, copays and coinsurance on those services accumulate toward the cap, and once the cap is reached, the member's medical cost sharing for the remainder of the year stops.

Prescription drugs bought at a pharmacy do not live in that bucket. They sit in the plan's Part D component — the drug benefit that a Medicare Advantage Prescription Drug plan bundles alongside the medical coverage. Part D has its own deductible, its own tier structure, its own coinsurance rules and its own separate out-of-pocket accounting. Spending in one bucket does not move the needle in the other.

So a member who is hospitalized in the spring, hits his medical MOOP by summer and then fills a specialty prescription in August is starting from scratch on the drug side. His card looks identical. His plan name has not changed. His explanation of benefits looks like the same document it always did. And the pharmacy register still asks him for money.

Why the single card creates the confusion

The confusion is structural, not accidental. Medicare Advantage's core marketing pitch is consolidation: one plan, one card, one customer service number, one annual notice of change instead of a Medigap policy plus a stand-alone drug plan. That pitch works because it flattens complexity. What it also does is hide the seam where two different regulatory frameworks meet.

Under the hood, a Medicare Advantage Prescription Drug plan is two contracts stapled together. The medical portion is governed by the rules that apply to Part C. The drug portion is governed by Part D rules, which are written differently, priced differently, and — importantly — administered in many cases by a pharmacy benefit manager rather than by the insurer's medical claims operation. Two claims systems. Two accumulators. Two sets of letters.

Members who previously had employer coverage are especially exposed. Most commercial plans since the Affordable Care Act have run a single integrated out-of-pocket maximum covering medical and pharmacy together. Someone who spent thirty years with that mental model, then aged into a Medicare Advantage plan, has every reason to assume the ceiling behaves the way it always did. It does not.

The drug side has its own ceiling — and it is not the one on the brochure

The Part D side is not unlimited. Federal law now caps what a Medicare drug beneficiary pays out of pocket for covered prescriptions in a plan year, replacing the older structure in which catastrophic-phase coinsurance kept charging a percentage indefinitely. That change was the single biggest improvement in the drug benefit in years for members with high-cost prescriptions, and it applies to Medicare Advantage drug plans just as it does to stand-alone ones.

But it is a second, independent ceiling. A member with heavy medical utilization and heavy pharmacy utilization can be exposed to both caps in the same year. The plan brochure's headline out-of-pocket maximum figure — the number members remember, because it is the number in the largest font — describes only the medical half. The worst-case total annual exposure is the medical ceiling plus the drug ceiling, and no marketing document presents it that way.

Two further wrinkles matter for anyone doing this math on a kitchen table:

• Only covered drugs count. A medication that is not on the plan's formulary generally contributes nothing to the drug out-of-pocket total, no matter how much the member pays. That is the failure mode that produces the largest unexpected bills.
• Where the drug is administered changes the bucket. A drug infused in a physician's office is typically a medical-benefit claim, counting toward the medical MOOP. The chemically similar drug self-administered at home is a pharmacy claim, counting toward the drug side. Site of care can reroute thousands of dollars from one counter to the other.
• Premiums never count. Monthly plan premiums and the Part B premium sit outside both accumulators entirely.

What enrollees and their families should check now

The practical defense is unglamorous: read the plan's Evidence of Coverage rather than the summary, and find the two separate out-of-pocket sections. They are there, and they are labeled differently. Then call the plan and ask for both accumulator balances — medical year-to-date and pharmacy year-to-date — as two distinct figures. If the representative gives one number, the question has not been answered.

Members already carrying expensive maintenance prescriptions should verify formulary placement before the plan year begins, not after. A drug that falls off a formulary at renewal converts a capped expense into an uncapped one. And anyone facing a choice between office-administered and self-administered versions of the same therapy should ask, in advance, which benefit will process the claim.

The market context behind the design

None of this is happening in a quiet corner of the insurance industry. Medicare Advantage has been the growth engine of the managed care sector for a decade, and the past two years have squeezed it hard: medical cost trend running above what insurers assumed when they filed bids, tighter federal risk-adjustment audits, and star-ratings disputes that decide bonus payments. Carriers have responded by trimming benefits, exiting unprofitable counties and reworking cost-sharing structures at the margins.

Members feel that pressure through the details — copay tiers that shift, prior authorization that tightens, formularies that move. In that environment, understanding which of a plan's two counters a given bill lands in stops being trivia and becomes the difference between a predictable year and a five-figure surprise. Equity markets closed the week broadly higher, with the S&P 500 tracker SPY at 773.26, up 0.61% on the day as of 21:17 GMT on August 7, 2026 — a reminder that the sector's investors and its enrollees are reading the same benefit designs from opposite ends.

The finish line the member thought he had crossed was real. There was just a second one behind it.

Frequently asked questions

Does hitting my Medicare Advantage out-of-pocket maximum stop my pharmacy bills?

No. The out-of-pocket maximum advertised on a Medicare Advantage plan applies to medical services — hospital stays, doctor visits, outpatient care and similar Part A and Part B items. Prescriptions filled at a pharmacy are processed under the plan's Part D drug benefit, which has its own separate out-of-pocket accounting and continues to charge cost sharing.

Why does one insurance card have two separate spending counters?

A Medicare Advantage Prescription Drug plan is effectively two contracts bundled together. The medical portion follows Part C rules, while the drug portion follows Part D rules and is often administered by a pharmacy benefit manager on a different claims system. Each side maintains its own accumulator, so spending on one does not reduce the other.

Is there any cap on Medicare Advantage prescription drug costs?

Yes. Federal law now caps what a Medicare beneficiary pays out of pocket for covered prescriptions in a plan year, replacing the older structure where catastrophic-phase coinsurance kept charging a percentage with no ceiling. That cap applies to Medicare Advantage drug plans too, but it is a second, independent limit on top of the medical maximum.

How can I find out where I stand on each counter?

Call the plan and ask specifically for two figures: your year-to-date medical out-of-pocket accumulation and your year-to-date prescription drug out-of-pocket accumulation. If the representative offers only one number, the question has not been answered. The plan's Evidence of Coverage document also lists both limits in separate sections.

Do drugs that are not on my plan's formulary count toward my drug spending limit?

Generally no. Only covered drugs on the plan's formulary contribute to the Part D out-of-pocket total. Money spent on a non-formulary medication typically does not move the counter at all, regardless of how much it costs. This is one of the most common sources of unexpectedly large bills for enrollees.

Does it matter where I receive a drug?

It can matter a great deal. A drug infused in a physician's office is usually processed as a medical claim and counts toward the medical out-of-pocket maximum. A comparable drug self-administered at home is typically a pharmacy claim counting toward the drug side. Site of care can shift substantial costs between the two counters.

Sources

• He Reached His Medicare Advantage Plan’s Out-of-Pocket Maximum. His Pharmacy Bills Kept Coming. — 24/7 Wall St

Photo: cottonbro studio · Pexels Licence — source